Structured intermittent treatment for HIV disease: Necessary concession or premature compromise?

被引：15

作者：

Havlir, DV ^{[1
]}

机构：

[1] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2002年 / 99卷 / 01期

关键词：

D O I：

10.1073/pnas.022629399

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：4 / 6

页数：3

共 31 条

[1]

APETREI C, 2001, 5 INT WORKSH HIV DRU, V6, P77

[2] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].

Barouch, DH ;

Santra, S ;

Schmitz, JE ;

Kuroda, MJ ;

Fu, TM ;

Wagner, W ;

Bilska, M ;

Craiu, A ;

Zheng, XX ;

Krivulka, GR ;

Beaudry, K ;

Lifton, MA ;

Nickerson, CE ;

Trigona, WL ;

Punt, K ;

Freed, DC ;

Guan, LM ;

Dubey, S ;

Casimiro, D ;

Simon, A ;

Davies, ME ;

Chastain, M ;

Strom, TB ;

Gelman, RS ;

Montefiori, DC ;

Lewis, MG ;

Emini, EA ;

Shiver, JW ;

Letvin, NL .

SCIENCE, 2000, 290 (5491) :486-492

[3] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[4] HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].

COFFIN, JM .

SCIENCE, 1995, 267 (5197) :483-489

[5] Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection [J].

Colven, R ;

Harrington, RD ;

Spach, DH ;

Cohen, CJ ;

Hooton, TM .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) :430-434

[6] HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [J].

Davey, RT ;

Bhat, N ;

Yoder, C ;

Chun, TW ;

Metcalf, JA ;

Dewar, R ;

Natarajan, V ;

Lempicki, RA ;

Adelsberger, JW ;

Millers, KD ;

Kovacs, JA ;

Polis, MA ;

Walker, RE ;

Falloon, L ;

Masur, H ;

Gee, D ;

Baseler, M ;

Dimitrov, DS ;

Fauci, AS ;

Lane, HC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15109-15114

[7] Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters [J].

Dybul, M ;

Chun, TW ;

Yoder, C ;

Hidalgo, B ;

Belson, M ;

Hertogs, K ;

Larder, B ;

Dewar, RL ;

Fox, CH ;

Hallahan, CW ;

Justement, JS ;

Migueles, SA ;

Metcalf, JA ;

Davey, RT ;

Daucher, M ;

Pandya, P ;

Baseler, M ;

Ward, DJ ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15161-15166

[8] Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study [J].

Fellay, J ;

Boubaker, K ;

Ledergerber, B ;

Bernasconi, E ;

Furrer, H ;

Battegay, M ;

Hirschel, B ;

Vernazza, P ;

Francioli, P ;

Greub, G ;

Flepp, M ;

Telenti, A .

LANCET, 2001, 358 (9290) :1322-1327

[9] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].

Finzi, D ;

Hermankova, M ;

Pierson, T ;

Carruth, LM ;

Buck, C ;

Chaisson, RE ;

Quinn, TC ;

Chadwick, K ;

Margolick, J ;

Brookmeyer, R ;

Gallant, J ;

Markowitz, M ;

Ho, DD ;

Richman, DD ;

Siliciano, RF .

SCIENCE, 1997, 278 (5341) :1295-1300

[10] The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection [J].

García, F ;

Plana, M ;

Ortiz, GM ;

Bonhoeffer, S ;

Soriano, A ;

Vidal, C ;

Cruceta, A ;

Arnedo, M ;

Gil, C ;

Pantaleo, G ;

Pumarola, T ;

Gallart, T ;

Nixon, DF ;

Miró, JM ;

Gatell, JM .

AIDS, 2001, 15 (09) :F29-F40

← 1 2 3 4 →